Browsing by Author "Vergote, Ignace"
Now showing 1 - 3 of 3
- Results Per Page
- Sort Options
Item Trial in Progress of Engot-Cx8/Gog-3024/Innovatv 205: Addition of A New Cohort Using First-Line Tisotumab Vedotin Plus Pembrolizumab Plus Carboplatin +/- Bevacizumab in Recurrent/Metastatic Cervical Cancer(2022) Vergote, Ignace; Mirza, Mansoor; Sehouli, Jalid; Lorusso, Domenica; Kose, Fatih; Cibula, David; Westermann, Anneke; Collins, Dearbhaile; Banerjee, Susana; Oaknin, Ana; Soumaoro, Ibrahima; Jain, Shweta; Monk, BradleyItem Trial in progress update on ENGOT-cx8/GOG-3024/innovaTV 205: Addition of a new cohort with first-line (1L) tisotumab vedotin (TV) plus pembrolizumab (pembro) plus carboplatin (carbo) +/- bevacizumab (bev) in recurrent/metastatic cervical cancer (r/mCC)(2022) Vergote, Ignace; Mirza, Mansoor Raza; Sehouli, Jalid; Lorusso, Domenica; Ose, Fatih K.; Cibula, David; Westermann, Anneke M.; Collins, Dearbhaile Catherine; Banerjee, Susana N.; Oaknin, Ana; Soumaoro, Ibrahima; Jain, Shweta; Monk, Bradley J.Item Trial in Progress Update on Engotcx8/Gog-3024/Innovatv 205: Addition of A New Cohort Using First-Line Tisotumab Vedotin Plus Pembrolizumab Plus Carboplatin - Bevacizumab in Recurrentimetastatic Cervical Cancer(2022) Vergote, Ignace; Mirza, Mansoor; Sehouli, Jalid; Lorusso, Domenico; Kose, Fatih; Cibula, David; Westermann, Anneke; Collins, Dearbhaile; Banerjee, Susana; Oaknin, Ana; Soumaoro, Ibrahima; Jain, Shweta; Monk, Bradley J.